These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16019476)

  • 41. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
    Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
    Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
    Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
    Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
    Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
    Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
    Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
    Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
    Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
    Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
    Agazie Y; Ischenko I; Hayman M
    Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells.
    Xie J; Qian J; Yang J; Wang S; Freeman ME; Yi Q
    Exp Hematol; 2005 May; 33(5):564-72. PubMed ID: 15850834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
    Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
    Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-7: Comprehensive review.
    Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
    Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.
    Fernandes MB; Gomes AM; Oliveira ML; Caldas J; Lúcio P; Kim R; Caye-Eude A; Pereira F; De Sousa AB; De Stefano A; Follo MY; Soares MV; Lacerda JF; Desterro J; Cavé H; Clappier E; Duarte X; Ribeiro P; Barata JT
    Haematologica; 2024 Aug; 109(8):2671-2675. PubMed ID: 38654666
    [No Abstract]   [Full Text] [Related]  

  • 56. Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications.
    Cardoso BA; Gírio A; Henriques C; Martins LR; Santos C; Silva A; Barata JT
    Braz J Med Biol Res; 2008 May; 41(5):344-50. PubMed ID: 18488097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
    Silva A; Laranjeira AB; Martins LR; Cardoso BA; Demengeot J; Yunes JA; Seddon B; Barata JT
    Cancer Res; 2011 Jul; 71(14):4780-9. PubMed ID: 21593192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-7 enhances the survival and maintains the size of naive T cells.
    Rathmell JC; Farkash EA; Gao W; Thompson CB
    J Immunol; 2001 Dec; 167(12):6869-76. PubMed ID: 11739504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
    Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
    Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway.
    Swainson L; Kinet S; Mongellaz C; Sourisseau M; Henriques T; Taylor N
    Blood; 2007 Feb; 109(3):1034-42. PubMed ID: 17023582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.